着床前診断、対象拡大へ　成人後発症の病気も―産科婦人科学会

　重い遺伝病を避けるために受精卵を選別する「着床前診断」について、日本産科婦人科学会（日産婦）は、対象を拡大する方針を決めた。「成人前に」死亡する恐れのある病気などに限ってきたが、年齢部分を「原則、成人前に」と変更する。成人後に発症する病気も含まれることになる。
　２６日の定時総会後の記者会見で明らかにした。日産婦は今後、内規の改定などに向けて議論する。（2021/06/26-20:59）

The Japan Society of Obstetrics and Gynecology said Saturday it plans to expand the scope of severe genetic diseases that are detected through preimplantation testing performed on fertilized eggs.
   While the testing has only been covering diseases that may force sufferers to die before they reach adulthood, the society plans to expand the coverage to also include diseases that develop during adulthood.
   The policy was unveiled at a press conference held after the society's regular general meeting on Saturday. The society will advance discussions in order to revise related internal regulations.
   In a report compiled in May, the society had indicated a plan to allow preimplantation testing to be performed to detect diseases that may cause death "before adulthood in principle." By using the expression "in principle," the society aims to leave open the possibility of diseases that occur during adulthood being covered by the testing, while stopping short of listing specific disease names.
   The society also said in the report that the testing should be performed to detect diseases requiring advanced treatment that takes a toll on the patient's body.